MESSIAEN, Peter

Email Alert RSS Feed

Profile

Full Name
MESSIAEN, Peter
Email
peter.messiaen@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Author:  Delforge, Marc

Results 1-4 of 4 (Search time: 0.001 seconds).

Issue DateTitleContributor(s)TypeCat.
12023Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in BelgiumNasreddine, Rakan; Florence, Eric; Yombi, Jean Cyr; Henrard, Sophie; Darcis, Gilles; Van Praet, Jens; Vandekerckhove, Linos D.; Allard, Sabine; Demeester, Remy; MESSIAEN, Peter; Ausselet, Nathalie; Delforge, Marc; De Wit, StephaneJournal ContributionA1
22023Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in BelgiumNasreddine, Rakan; Yombi, Jean Cyr; Darcis, Gilles; Florence, Eric; Allard, Sabine D.; De Scheerder, Marie-Angelique; Henrard, Sophie; Demeester , Remy; MESSIAEN, Peter; Ausselet, Nathalie; Loeckx, Matthias; Delforge, Marc; De Wit, StephaneJournal ContributionA1
32022A retrospective, multicenter study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in BelgiumNasreddine, Rakan; Florence, Eric; Yombi, Jean Cyr; Henrard, Sophie; Darcis, Gilles; Van Praet, Jens; Vandekerckhove, Linos; Allard, Sabine; Demeester, Rémy; MESSIAEN, Peter; Ausselet, Nathalie; Delforge, Marc; De Wit, StéphaneConference MaterialC2
42021Clinical characteristics and outcomes of COVID‐19 in people living with HIV in Belgium: A multicenter, retrospective cohortNasreddine, Rakan; Florence, Eric; Moutschen, Michel; Yombi, Jean‐cyr; Goffard, Jean‐christophe; Derdelinckx, Inge; Lacor, Patrick; Vandekerckhove, Linos; MESSIAEN, Peter; Vandecasteele , Stefaan; Delforge, Marc; De Wit, StéphaneJournal ContributionA1